You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:


Last Updated: February 19, 2020

DrugPatentWatch Database Preview

Hydrochlorothiazide; spironolactone - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for hydrochlorothiazide; spironolactone and what is the scope of patent protection?

Hydrochlorothiazide; spironolactone is the generic ingredient in three branded drugs marketed by Gd Searle Llc, Ascot, Mutual Pharm, Mylan, Purepac Pharm, Sun Pharm Industries, Superpharm, Watson Labs, Yaopharma Co Ltd, Ivax Pharms, Lederle, Parke Davis, Upsher Smith, Usl Pharma, and Vangard, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for hydrochlorothiazide; spironolactone. Five suppliers are listed for this compound.

Summary for hydrochlorothiazide; spironolactone
Recent Clinical Trials for hydrochlorothiazide; spironolactone

Identify potential brand extensions & 505(b)(2) entrants

Medical University of BialystokN/A
Shanghai Jiao Tong University School of MedicinePhase 4
Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranPhase 4

See all hydrochlorothiazide; spironolactone clinical trials

Pharmacology for hydrochlorothiazide; spironolactone
Synonyms for hydrochlorothiazide; spironolactone
Hydrochlorothiazide / Spironolactone
Hydrochlorothiazide mixture with Spironolactone
MP 40 [Pill Imprint]

US Patents and Regulatory Information for hydrochlorothiazide; spironolactone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Superpharm SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 089137-001 Aug 26, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 086026-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; spironolactone TABLET;ORAL 087398-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.